RedHill Biopharma Ltd.
RDHL · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $3 | $3 | $5 | $2 |
| Short-Term Investments | $0 | $0 | $0 | $3 |
| Receivables | $6 | $5 | $4 | $3 |
| Inventory | $3 | $3 | $4 | $4 |
| Other Curr. Assets | $0 | $1 | $0 | $1 |
| Total Curr. Assets | $13 | $13 | $12 | $12 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $6 | $6 | $6 | $6 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $6 | $6 | $6 | $6 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $18 | $18 | $18 | $18 |
| Liabilities | – | – | – | – |
| Payables | $1 | $1 | $8 | $1 |
| Short-Term Debt | $0 | $0 | $1 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $21 | $21 | $14 | $21 |
| Total Curr. Liab. | $22 | $22 | $22 | $22 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $1 | $1 | $1 | $1 |
| Total NC Liab. | $1 | $1 | $1 | $1 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $23 | $23 | $23 | $23 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $63 | $63 | $35 | $35 |
| Retained Earnings | -$418 | -$418 | -$415 | -$415 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $350 | $350 | $375 | $375 |
| Total Equity | -$4 | -$4 | -$5 | -$5 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $18 | $18 | $18 | $18 |
| Net Debt | -$3 | -$3 | -$4 | -$2 |